Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice

Human Molecular Genetics

Volumn 17, Issue 10, 2008, Pages 1386-1396

  Jugloff, Denis G M ^a,b   Vandamme, Katrina ^a   Logan, Richard ^a   Visanji, Naomi P ^a   Brotchie, Jonathan M ^a   Eubanks, James H ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; METHYL CPG BINDING PROTEIN 2;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CROSS BREEDING; FOREBRAIN; GENE MUTATION; GENE TARGETING; LOCOMOTION; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REARING; RETT SYNDROME; TRANSGENE; TRANSGENIC MOUSE; X CHROMOSOME LINKED DISORDER;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; GENE TARGETING; HUMANS; MALE; MATERNAL BEHAVIOR; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR ACTIVITY; NEURONS; PROSENCEPHALON; RETT SYNDROME; TRANSGENES;

MUS; MUS MUSCULUS;

EID: 43049099355     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn026     Document Type: Article

References (36)

1. Rett, A. (1966) On an unusual brain atrophy syndrome in hyperammonermia, in childhood. Wien. Med. Wochenschr, 116, 723-726.
2. Hagberg, B., Aicardi, J., Dias, K. and Ramos, O. (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: RettRs syndrome: report of 35 cases. Ann. Neurol, 14, 471-479.
3. Kerr, A.M., Cooper, R. and Southall, D. (1991) Rett syndrome. Acta Neurol. Scand., 84, 458-459.
4. Segawa, M. and Nomura, Y. (2005) Rett syndrome. Curr. Opin. Neurol. 18, 97-104.
5. Jellinger, K., Armstrong, D., Zoghbi, H.Y. and Percy, A.K. (1988) Neuropathology of Rett syndrome. Acta Neuropathol. (Bert.), 76 142-158.
6. Johnston, M.V., Oh, J., Pevsner, J., Blue, M.E. and Naidu, S. (2001) Neurobiology of Rett syndrome: A genetic disorder of synapse development. Brain Dev., 1, S206-S213.
7. Glaze, D.G. (2005) Neurophysiology of Rett syndrome. J. Child. Neurol., 20, 740-746.
8. Armstrong, D.D., Dunn, K. and Antalffy, B. (1998) Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J. Neuropathol. Exp. Neurol., 57, 1013-1017.
9. Kishi, N. And Macklis, J.D. (2005) Dissecting MECP2 function in the central nervous system. J. Child. Neurol., 20, 753-759.
10. Moretti, P. and Zoghbi, H.Y. (2006) MeCP2 dysfunction in Rett syndrome and related disorders. Curr. Opin. Genet. Dev., 16, 276-281.
11. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome'is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23 185-188.
12. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. and Bird, A. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet., 27, 322-326.
13. Chen, R.Z., Akbarian, S., Tudor, M. and Jaenisch, R. (2001) Deficiency of methyl-CpG binding protein-2, in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet., 27, 327-331.
14. Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., Armstrong, D., Paylor, R. and Zoghbi, H. (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron, 35, 243-254.
15. Pelka, G.J., Watson, C.M., Radziewic, T., Hayward, M., Lahooti, H., Christodoulou, J. and Tam, P.P. (2006) Mecp2 deficiency is associated with learning and cognitive deficits ind altered gene activity in the hippocampal region of mice. Brain, 129, 887-898.
16. Collins, A.L., Levenson, J.M., Vilaythong, A.P., Richman, R., Armstrong, D.L., Noebels, J.L., David-Sweatt, J. and Zoghbi, H.Y. (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet., 13, 2679-2689.
17. Luikenhuis, S., Giacometti, E., Beard, C.F. and Jaenisch, R. (2004) Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl Acad. Sci. USA, 101, 6033-6038.
18. Giacometti, E., Luikenhuis, S., Beard, C. and Jaenisch, R. (2007) Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc. Natl Acad. Sci. USA, 104, 1931-1936.
19. Alvarez-Saavedra, M., Saezm, M.A., Kang, D., Zoghbi, H.Y. and Young, J.I. (2007) Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Hum. Mol. Genet. 16, 2315-2325.
20. Guy, J., Gan, J., Selfridge, J., Cobb, S. and Bird, A. (2007) Reversal of neurological defects in a mouse model of Rett syndrome; Science 315, 1143-1147.
21. Shahbazian, M.D. and Zoghbi, H.Y. (2002) Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am. J. Hum Genet., 71, 1259-1272.
22. Mansuy, I.M., Winder, D.G., Moallem, T.M., Osman, M., Mayford, M., Hawkins, R.D. and Kandel, E.R. (1998) Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron, 21, 257-265.
23. Stearns N. A., Schaevitz L.R., Bowling, H., Nag, N., Berger, U.V. and Berger-Sweeney, J. (2007) Behavioral and anatomical abnormalities in Mecp2 mutant mice: A model for Rett syndrome. Neuroscience, 146 907-921.
24. Baron, U. and Bujard, H. (2000) Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advances. Meth. Enzymol., 327, 401-421.
25. Forster, K., Helbl, V., Lederer, T., Urlinger, S., Wittenburg, N. and Hillen, W. (1999) Tetracycline-inducible expression systems with reduced basal activity in mammalian cells. Nucleic Acids Res., 27, 708-710.
26. LaSalle, J.M., Goldstine, J., Balmer, D. and Greco, C.M. (2001) Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum. Mol. Genet., 10, 1729-1740.
27. Braunschweig, D., Simcox, T., Samaco, R.C. and LaSalle, J.M. (2004) X-chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2 - mouse brain. Hum. Mol. Genet. 13, 1275-1286.
28. Morton, S.M. and Bastian, A.J. (2004) Cerebellar control of balance and locomotion. Neuroscientist, 10, 247-259.
29. McGill, B.E., Bundle, S.F., Yaylaoglu, M.B., Carson, J.P., Thaller, C. and Zoghbi, H.Y. (2006) Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA, 103 18261-18272.
30. Mayford, M., Bach, M.E., Huang, Y.Y., Wang, L., Hawkins, R.D. and Kandel, E.R. (1996) Control of memory formation through regulated expression of a CaMKII transgene. Science, 274, 1678-1683.
31. Hogan, B., Beddington, R., Constantinini, F. and Lacy, E. (1994) Manipulating the Mouse Embryo - a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
32. Jugloff, D.G., Logan, R. and Eubanks, J.H. (2006) Breeding and maintenance of an Mecp2-deficient mouse model of Rett syndrome. J. Neurosci. Meth., 154, 89-95.
33. Asaka, Y., Jugloff, D.G., Zhang, L., Eubanks, J.H. and Fitzsimonds, R.M. (2006) Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol. Dis., 21, 217-227.
34. Jung, B.P., Jugloff, D.G., Zhang, G., Logan, R., Brown, S. and Eubanks, J.H. (2003) The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J. Neurobiol., 55, 86-96.
35. Nash, J.E., Johnston, T.H. Collingridge, G.L., Garner. C.C. and Brotchie, J.M. (2005) Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesia. FASEB J., 19 583-585.
36. Visanji, N.P., Millan, M.J. and Biotchie, J.M. (2006) Actions at sites other than D(3) receptors mediate the effects of BP897 on 1-DOPA-induced hyperactivity in monoamine-depleted rats. Exp. Neurol., 202, 85-92.